Apellis Pharmaceuticals, Inc. logo APLS - Apellis Pharmaceuticals, Inc.

Inactive Ticker APLS is not actively trading. Quotes and analytics may be stale.
Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 1
BUY 17
HOLD 6
SELL 1
STRONG
SELL 0
| PRICE TARGET: $33.40 DETAILS
HIGH: $48.00
LOW: $19.00
MEDIAN: $35.00
CONSENSUS: $33.40
DOWNSIDE: 18.60%

Profitability Ratios

Ratio Value
GP Margin 89.8%
EBIT Margin 6.8%
EBITDA Margin 7.0%
Operating Margin 5.5%
Pretax Margin 2.4%
Cont. Ops Margin 2.2%
Net Margin 2.2%
Bottom Line Margin 2.2%

Liquidity Ratios

Ratio Value
Current Ratio 3.14
Quick Ratio 2.70
Solvency Ratio 0.034
Cash Ratio 1.45

Valuation Ratios

Ratio Value
Price/Earnings
141.40
Hist. avg: 141.4
Peers avg: 20.6
PEG Ratio -1.27
Forward PEG -1.27
Price/Book 8.55
Price/Sales 3.15
Price/FCF 70.33
Price/Op Cash Flow 69.84

Debt Ratios

Ratio Value
Debt/Assets 0.4523
Debt/Equity 1.3138
Debt/Capital 0.5678
Long-Term Debt/Capital 0.5023
Financial Leverage 2.90

Cash Flow Ratios

Ratio Value
Working Capital Turnover 1.55
Operating Cash Flow Ratio 0.140
Operating Cash Flow/Sales 4.5%
Free Cash Flow/Operating Cash Flow 99.3%

Coverage Ratios

Ratio Value
Debt Service Coverage 0.47
Interest Coverage 1.2504
Short-Term Operating Cash Flow Coverage 0.45
Operating Cash Flow Coverage 0.09
Capital Expenditure Coverage 144.81
Dividend + Capital Expenditure Coverage 144.81

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 7.97
EPS 0.178
Debt/Share 4.2106
Cash/Share 3.71
Book Value/Share 2.94
Tangible BV/Share 2.94
Equity/Share 2.94
Operating Cash Flow/Share 0.360
Capital Expenditure/Share 0.002
FCF/Share 0.357

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 0.929
Earnings Before Tax/EBIT 0.435
Price/Fair Value 8.55
Debt/Market Cap 0.1498
Effective Tax Rate 7.1%
Enterprise Value Multiple 45.49